MRNA logo

Moderna (MRNA) Retained Earnings

Annual Retained Earnings

$13.61 B
-$4.71 B-25.73%

31 December 2023

MRNA Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

$11.16 B
+$13.00 M+0.12%

30 September 2024

MRNA Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRNA Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-25.7%-16.6%
3 y3 years+706.3%+119.3%
5 y5 years+1451.6%+915.2%

MRNA Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-25.7%+706.3%-39.3%+119.3%
5 y5 years-25.7%+706.3%-39.3%+597.5%
alltimeall time-25.7%+706.3%-39.3%+597.5%

Moderna Retained Earnings History

DateAnnualQuarterly
Sept 2024
-
$11.16 B(+0.1%)
June 2024
-
$11.15 B(-10.3%)
Mar 2024
-
$12.43 B(-8.6%)
Dec 2023
$13.61 B(-25.7%)
$13.61 B(+1.6%)
Sept 2023
-
$13.39 B(-21.3%)
June 2023
-
$17.02 B(-7.5%)
Mar 2023
-
$18.40 B(+0.4%)
Dec 2022
$18.32 B(+84.0%)
$18.32 B(+8.7%)
Sept 2022
-
$16.86 B(+6.6%)
June 2022
-
$15.81 B(+16.1%)
Mar 2022
-
$13.62 B(+36.7%)
Dec 2021
$9.96 B(-543.8%)
$9.96 B(+95.6%)
Sept 2021
-
$5.09 B(+189.7%)
June 2021
-
$1.76 B(-271.7%)
Mar 2021
-
-$1.02 B(-54.4%)
Dec 2020
-$2.24 B(+50.0%)
-$2.24 B(+13.8%)
Sept 2020
-
-$1.97 B(+13.4%)
June 2020
-
-$1.74 B(+7.2%)
Mar 2020
-
-$1.62 B(+8.3%)
Dec 2019
-$1.50 B(+48.7%)
-$1.50 B(+9.3%)
Sept 2019
-
-$1.37 B(+9.9%)
June 2019
-
-$1.25 B(+12.2%)
Mar 2019
-
-$1.11 B(+10.4%)
Dec 2018
-$1.01 B(+61.9%)
-$1.01 B(+15.2%)
Sept 2018
-
-$874.03 M(+40.5%)
Dec 2017
-$621.89 M(+70.0%)
-$621.89 M(>+9900.0%)
Sept 2017
-
-$5.18 M(+23.1%)
June 2017
-
-$4.21 M(+38.6%)
Mar 2017
-
-$3.03 M(+55.5%)
Dec 2016
-$365.72 M(+9.3%)
-
Dec 2016
-
-$1.95 M(-99.4%)
Sept 2016
-
-$334.06 M(+0.0%)
June 2016
-
-$334.03 M(+0.2%)
Mar 2016
-
-$333.38 M(-0.3%)
Dec 2015
-$334.45 M(-1.0%)
-$334.45 M(-0.2%)
Sept 2015
-
-$335.01 M(-0.4%)
June 2015
-
-$336.47 M(-0.3%)
Mar 2015
-
-$337.37 M(-0.1%)
Dec 2014
-$337.79 M(+2.0%)
-$337.79 M(-1.7%)
Sept 2014
-
-$343.59 M(+2.1%)
June 2014
-
-$336.47 M(-1.2%)
Mar 2014
-
-$340.39 M(+2.7%)
Dec 2013
-$331.31 M(+0.5%)
-$331.31 M(+0.6%)
Sept 2013
-
-$329.35 M(+0.3%)
June 2013
-
-$328.37 M(+0.0%)
Mar 2013
-
-$328.36 M(-0.4%)
Dec 2012
-$329.74 M(+3.0%)
-$329.74 M(+1.2%)
Sept 2012
-
-$325.69 M(+0.5%)
June 2012
-
-$323.94 M(-0.3%)
Mar 2012
-
-$325.02 M(+1.5%)
Dec 2011
-$320.19 M(+10.1%)
-$320.19 M(+5.9%)
Sept 2011
-
-$302.41 M(+1.5%)
June 2011
-
-$298.02 M(+1.2%)
Mar 2011
-
-$294.44 M(+1.3%)
Dec 2010
-$290.77 M(+10.6%)
-$290.77 M(+10.6%)
Sept 2010
-
-$263.02 M(-4.9%)
June 2010
-
-$276.61 M(+1.5%)
Mar 2010
-
-$272.51 M(+3.6%)
Dec 2009
-$263.02 M(+3.5%)
-$263.02 M(+0.3%)
Sept 2009
-
-$262.23 M(+2.7%)
June 2009
-
-$255.22 M(+3.0%)
Mar 2009
-
-$247.69 M(-2.5%)
DateAnnualQuarterly
Dec 2008
-$254.09 M(+30.4%)
-$254.09 M(+5.1%)
Sept 2008
-
-$241.78 M(+7.1%)
June 2008
-
-$225.71 M(+6.8%)
Mar 2008
-
-$211.38 M(+8.5%)
Dec 2007
-$194.87 M(+36.8%)
-$194.87 M(+6.6%)
Sept 2007
-
-$182.85 M(+9.9%)
June 2007
-
-$166.40 M(+8.0%)
Mar 2007
-
-$154.03 M(+8.1%)
Dec 2006
-$142.49 M(+23.2%)
-$142.49 M(+8.1%)
Sept 2006
-
-$131.83 M(+6.3%)
June 2006
-
-$124.02 M(+0.5%)
Mar 2006
-
-$123.46 M(+6.8%)
Dec 2005
-$115.62 M(+38.5%)
-$115.62 M(+8.4%)
Sept 2005
-
-$106.70 M(+9.0%)
June 2005
-
-$97.88 M(+9.3%)
Mar 2005
-
-$89.54 M(+7.3%)
Dec 2004
-$83.45 M(+52.2%)
-$83.45 M(+7.6%)
Sept 2004
-
-$77.53 M(+10.8%)
June 2004
-
-$69.98 M(+12.0%)
Mar 2004
-
-$62.49 M(+13.9%)
Dec 2003
-$54.84 M(+4.1%)
-$54.84 M(+12.1%)
Sept 2003
-
-$48.93 M(+14.6%)
June 2003
-
-$42.68 M(-23.3%)
Mar 2003
-
-$55.63 M(+5.5%)
Dec 2002
-$52.70 M(+34.3%)
-$52.70 M(+12.4%)
Sept 2002
-
-$46.91 M(+7.8%)
June 2002
-
-$43.50 M(+3.5%)
Mar 2002
-
-$42.04 M(+7.1%)
Dec 2001
-$39.23 M(+30.8%)
-$39.23 M(+8.4%)
Sept 2001
-
-$36.21 M(+5.3%)
June 2001
-
-$34.38 M(+6.4%)
Mar 2001
-
-$32.32 M(+7.7%)
Dec 2000
-$30.00 M(+47.8%)
-$30.00 M(+4.4%)
Sept 2000
-
-$28.73 M(+16.2%)
June 2000
-
-$24.74 M(+10.0%)
Mar 2000
-
-$22.49 M(+10.8%)
Dec 1999
-$20.30 M(+69.2%)
-$20.30 M(+15.3%)
Sept 1999
-
-$17.60 M(+12.8%)
June 1999
-
-$15.60 M(+9.9%)
Mar 1999
-
-$14.20 M(+18.3%)
Dec 1998
-$12.00 M(+8.1%)
-$12.00 M(+11.1%)
Sept 1998
-
-$10.80 M(+1.9%)
June 1998
-
-$10.60 M(-2.8%)
Mar 1998
-
-$10.90 M(-1.8%)
Dec 1997
-$11.10 M(+70.8%)
-$11.10 M(+22.0%)
Sept 1997
-
-$9.10 M(+16.7%)
June 1997
-
-$7.80 M(+13.0%)
Mar 1997
-
-$6.90 M(+13.1%)
Dec 1996
-$6.50 M(+4.8%)
-
Sept 1996
-
-$6.10 M(-1.6%)
June 1996
-$6.20 M(0.0%)
-$6.20 M(-1.6%)
Mar 1996
-
-$6.30 M(-3.1%)
Dec 1995
-
-$6.50 M(+3.2%)
Sept 1995
-
-$6.30 M(+1.6%)
June 1995
-$6.20 M(0.0%)
-$6.20 M(+1.6%)
Mar 1995
-
-$6.10 M(0.0%)
Dec 1994
-
-$6.10 M(0.0%)
Sept 1994
-
-$6.10 M(-1.6%)
June 1994
-$6.20 M
-$6.20 M(-3.1%)
Mar 1994
-
-$6.40 M(0.0%)
Dec 1993
-
-$6.40 M(0.0%)
Sept 1993
-
-$6.40 M

FAQ

  • What is Moderna annual retained earnings?
  • What is the all time high annual retained earnings for Moderna?
  • What is Moderna annual retained earnings year-on-year change?
  • What is Moderna quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Moderna?
  • What is Moderna quarterly retained earnings year-on-year change?

What is Moderna annual retained earnings?

The current annual retained earnings of MRNA is $13.61 B

What is the all time high annual retained earnings for Moderna?

Moderna all-time high annual retained earnings is $18.32 B

What is Moderna annual retained earnings year-on-year change?

Over the past year, MRNA annual retained earnings has changed by -$4.71 B (-25.73%)

What is Moderna quarterly retained earnings?

The current quarterly retained earnings of MRNA is $11.16 B

What is the all time high quarterly retained earnings for Moderna?

Moderna all-time high quarterly retained earnings is $18.40 B

What is Moderna quarterly retained earnings year-on-year change?

Over the past year, MRNA quarterly retained earnings has changed by -$2.22 B (-16.61%)